LENZ Therapeutics, Inc.
LENZ
$4.73
$0.132.83%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -31.92M | -41.49M | -35.90M | -16.70M | -14.91M |
| Total Depreciation and Amortization | 110.00K | 111.00K | 107.00K | 125.00K | 19.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 4.34M | 4.42M | 3.27M | 2.69M | 1.75M |
| Change in Net Operating Assets | -11.25M | 3.38M | -503.00K | 5.30M | 1.63M |
| Cash from Operations | -38.71M | -33.58M | -33.03M | -8.59M | -11.51M |
| Capital Expenditure | -16.00K | -18.00K | -38.00K | -439.00K | -240.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 37.77M | 33.18M | -89.77M | -3.89M | -174.00K |
| Cash from Investing | 37.75M | 33.16M | -89.81M | -4.33M | -414.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 395.00K | 14.00K | 122.62M | 598.00K | 26.49M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 395.00K | 14.00K | 122.62M | 598.00K | 26.49M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -564.00K | -407.00K | -220.00K | -12.32M | 14.57M |